Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2005-06-01 (20 years)Status: ActiveBusiness sector: Location et location-bail d'autres biens personnels et domestiquesLocation: HYERES (83400), Var
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
AZUR MEDICAL : revenue, balance sheet and financial ratios
AZUR MEDICAL is a French company
founded 20 years ago,
specialized in the sector Location et location-bail d'autres biens personnels et domestiques.
Based in HYERES (83400),
this company of category PME
shows in 2022 a revenue of 377 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - AZUR MEDICAL (SIREN 482287869)
Indicator
2022
2021
2020
Revenue
377 029 €
N/C
N/C
Net income
-8 411 €
17 368 €
21 600 €
EBITDA
10 945 €
N/C
N/C
Net margin
-2.2%
N/C
N/C
Revenue and income statement
In 2022, AZUR MEDICAL achieves revenue of 377 k€. After deducting consumption (140 k€), gross margin stands at 237 k€, i.e. a rate of 63%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 11 k€, representing 2.9% of revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -8 k€ (-2.2% of revenue), which will impact equity.
Revenue (2022)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
377 029 €
Gross margin (2022)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
236 583 €
EBITDA (2022)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
10 945 €
EBIT (2022)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-8 403 €
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-8 411 €
EBITDA margin (2022)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
2.9%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 2.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.659%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.339%
Cash flow / Revenue (2022)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
2.911%
Repayment capacity (2022)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.046
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
Debt ratio
21.593
3.956
0.659
Financial autonomy
46.009
61.726
61.339
Repayment capacity
None
None
0.046
Cash flow / Revenue
None%
None%
2.911%
Sector positioning
Debt ratio
0.662022
2020
2021
2022
Q1: 0.0
Med: 18.05
Q3: 97.74
Good-28 pts over 3 years
In 2022, the debt ratio of AZUR MEDICAL (0.66) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.34%2022
2020
2021
2022
Q1: 9.19%
Med: 35.2%
Q3: 61.31%
Excellent+16 pts over 3 years
In 2022, the financial autonomy of AZUR MEDICAL (61.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.05 years2022
2022
Q1: 0.0 years
Med: 0.03 years
Q3: 1.43 years
Average
In 2022, the repayment capacity of AZUR MEDICAL (0.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 133.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
133.186
Interest coverage (2022)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.073
Liquidity indicators evolution AZUR MEDICAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
Liquidity ratio
111.25
132.677
133.186
Interest coverage
None
None
0.073
Sector positioning
Liquidity ratio
133.192022
2020
2021
2022
Q1: 102.27
Med: 177.82
Q3: 316.78
Average+8 pts over 3 years
In 2022, the liquidity ratio of AZUR MEDICAL (133.19) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.07x2022
2022
Q1: 0.0x
Med: 0.04x
Q3: 1.23x
Good
In 2022, the interest coverage of AZUR MEDICAL (0.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 9 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 39 days. Favorable situation: supplier credit is longer than customer credit by 30 days. Inventory turnover is 40 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 39 days of revenue, i.e. 40 k€ to permanently finance.
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
40 421 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
9 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
39 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
40 j
WCR in days of revenue (2022)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
39 j
WCR and payment terms evolution AZUR MEDICAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
Operating WCR
0 €
0 €
40 421 €
Inventory turnover (days)
0
0
40
Customer payment term (days)
0
0
9
Supplier payment term (days)
0
0
39
Positioning of AZUR MEDICAL in its sector
Comparison with sector Location et location-bail d'autres biens personnels et domestiques
Valuation estimate
Based on 69 transactions of similar company sales
(all years),
the value of AZUR MEDICAL is estimated at
90 588 €
(range 42 856€ - 161 436€).
With an EBITDA of 10 945€, the sector multiple of 4.9x is applied.
The price/revenue ratio is 0.40x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2022
69 tx
42k€90k€161k€
90 588 €Range: 42 856€ - 161 436€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
10 945 €×4.9x
Estimation53 801 €
23 094€ - 116 138€
Revenue Multiple30%
377 029 €×0.40x
Estimation151 901 €
75 794€ - 236 934€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Location et location-bail d'autres biens personnels et domestiques)
Compare AZUR MEDICAL with other companies in the same sector:
The headquarters of AZUR MEDICAL is located in HYERES (83400), in the department Var.
Where to find the tax return of AZUR MEDICAL ?
The tax return of AZUR MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does AZUR MEDICAL operate?
AZUR MEDICAL operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart